Leo He - 2Monoceros Biosystems LLC | 人才画像

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 19 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Supplementary Table S1 from the SOS1 Inhibitor MRTX0902 Blocks KRAS Activation and Demonstrates Antitumor Activity in Cancers Dependent on KRAS Nucleotide Loading

Niranjan Sudhakar, Larry Yan, Fadia Qiryaqos,Lars D. Engstrom,Jade Laguer,Andrew Calinisan,Allan Hebbert,Laura Waters,Krystal Moya,Vickie Bowcut, Laura Vegar, John M. Ketcham,Anthony Ivetac, Christopher R. Smith,J. David Lawson,Lisa Rahbaek, Jeffrey Clarine,Natalie Nguyen, Barbara Saechao, Cody Parker, Adam J. Elliott,Darin Vanderpool,Leo He, Laura D. Hover,Julio Fernandez-Banet,Silvia Coma,Jonathan A. Pachter, Jill Hallin,Matthew A. Marx,David M. Briere,James G. Christensen,Peter Olson,Jacob Haling, Shilpi Khare

crossref（2024）

Cited0Views0Bibtex

Supplementary Figure S6 from the SOS1 Inhibitor MRTX0902 Blocks KRAS Activation and Demonstrates Antitumor Activity in Cancers Dependent on KRAS Nucleotide Loading

crossref（2024）

Cited0Views0Bibtex

Supplementary Materials and Methods from the SOS1 Inhibitor MRTX0902 Blocks KRAS Activation and Demonstrates Antitumor Activity in Cancers Dependent on KRAS Nucleotide Loading

Niranjan Sudhakar, Larry Yan, Fadia Qiryaqos,Lars D. Engstrom,Jade Laguer,Andrew Calinisan,Allan Hebbert,Laura Waters,Krystal Moya,Vickie Bowcut, Laura Vegar, John M. Ketcham,Anthony Ivetac, Christopher R. Smith,J. David Lawson,Lisa Rahbaek, Jeffrey Clarine,Natalie Nguyen, Barbara Saechao, Cody Parker, Adam J. Elliott,Darin Vanderpool,Leo He, Laura D. Hover,Julio Fernandez-Banet,Silvia Coma,Jonathan A. Pachter,Jill Hallin,Matthew A. Marx,David M. Briere,James G. Christensen,Peter Olson,Jacob Haling, Shilpi Khare

crossref（2024）

Cited0Views0Bibtex

Supplementary Table S3 from the SOS1 Inhibitor MRTX0902 Blocks KRAS Activation and Demonstrates Antitumor Activity in Cancers Dependent on KRAS Nucleotide Loading

crossref（2024）

Cited0Views0Bibtex

Supplementary Figure S7 from the SOS1 Inhibitor MRTX0902 Blocks KRAS Activation and Demonstrates Antitumor Activity in Cancers Dependent on KRAS Nucleotide Loading

crossref（2024）

Cited0Views0Bibtex

Supplementary Table S2 from the SOS1 Inhibitor MRTX0902 Blocks KRAS Activation and Demonstrates Antitumor Activity in Cancers Dependent on KRAS Nucleotide Loading

crossref（2024）

Cited0Views0Bibtex

The SOS1 Inhibitor MRTX0902 Blocks KRAS Activation and Demonstrates Antitumor Activity in Cancers Dependent on KRAS Nucleotide Loading

MOLECULAR CANCER THERAPEUTICSno. 10 (2024): 1418-1430

Cited0Views0WOSBibtex

Abstract 2779: Identification of Mechanism-Based Combination Targets Effective with the MTA-cooperative PRMT5 Inhibitor MRTX1719 for the Treatment of MTAP Deleted Cancers

Laura Waters,Ruth Aranda,Krystal Moya,Victoria Bowcut,David Trinh,Allan Hebbert,Leo He,Laura D. Hover,Julio Fernandez-Banet,Jill Hallin,David M. Briere,James G. Christensen,Peter A. Olson,Lars D. Engstrom

Cancer Researchno. 7_Supplement (2023): 2779-2779

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn